Home > Insider Trading > Filing (0001209191-16-093150)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1290149	Pronai Therapeutics Inc	DNAI	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1647663	Wendi Rodigueza	C/O Pronai Therapeutics, Inc., 2150 885 West Georgia St., Vancouver A1 V6C 3E8	Chief Scientific Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2016-01-20	1,000	$9.59	158,276	No	4	S	Direct
Common Stock	Disposition	2016-01-21	1,000	$10.32	157,276	No	4	S	Direct
Common Stock	Disposition	2016-01-22	1,000	$9.66	156,276	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.30 to $10.37 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.